Global Leuprolide Acetate Market Is Expected to Grow At A CAGR of 3.8% from 2020 to 2027

Leuprolide acetate exerts its pharmacological effect by suppressing the gonadotropin secretion of luteinizing and follicle-stimulating hormone which finally suppresses the gonadal sex steroid production. It is under clinical trial investigation for determining its therapeutic efficacy and safety in the treatment of polycystic ovary syndrome, premenstrual syndrome, functional bowel diseases, etc. Endometriosis is dominating the clinical application segment for the leuprolide acetate market. According to the recent statistics provided by the American Cancer Society (ACS), approximately 10% of the women population worldwide are suffering from endometriosis. Shorter menstrual length, early age…

Read More